41
Views
78
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Control of α Subunit of Eukaryotic Translation Initiation Factor 2 (eIF2α) Phosphorylation by the Human Papillomavirus Type 18 E6 Oncoprotein: Implications for eIF2α-Dependent Gene Expression and Cell Death

, , , , , , , & show all
Pages 3415-3429 | Received 10 Oct 2003, Accepted 12 Jan 2004, Published online: 27 Mar 2023

REFERENCES

  • Adamson, E. D., and Mercola D.. 2002. Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumour Biol. 23:93–102.
  • Balachandran, S., Kim C. N., Yeh W. C., Mak T. W., Bhalla K., and Barber G. N.. 1998. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17:6888–6902.
  • Benedict, C. A., Norris P. S., and Ware C. F.. 2002. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3:1013–1018.
  • Beretta, L., Gabbay M., Berger R., Hanash S. M., and Sonenberg N.. 1996. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q-associated leukemias. Oncogene 12:1593–1596.
  • Beyaert, R., Heyninck K., and Van Huffel S.. 2000. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem. Pharmacol. 60:1143–1151.
  • Brush, M. H., Weiser D. C., and Shenolikar S.. 2003. Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2. Mol. Cell. Biol. 23:1292–1303.
  • Burgering, B. M., and Kops G. J.. 2002. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27:352–360.
  • Burgert, H. G., Ruzsics Z., Obermeier S., Hilgendorf A., Windheim M., and Elsing A.. 2002. Subversion of host defense mechanisms by adenoviruses. Curr. Top. Microbiol. Immunol. 269:273–318.
  • Chen, J. J. 2000. Heme-regulated eIF2α kinase, p. 529–546. In Sonenberg N., Hershey J. W. B., and Mathews M. B. (ed.), Translational control of gene expression. Cold Spring Harbor Laboratory Press, New York, N.Y.
  • Chomczynski, P., and Sacchi N.. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
  • Christopher, S. A., Diegelman P., Porter C. W., and Kruger W. D.. 2002. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res. 62:6639–6644.
  • Clemens, M. J. 2001. Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis. Prog. Mol. Subcell. Biol. 27:57–89.
  • Clemens, M. J., and Elia A.. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:503–524.
  • Corbett, J. M., Dunn M. J., Posch A., and Gorg A.. 1994. Positional reproducibility of protein spots in two-dimensional polyacrylamide gel electrophoresis using immobilised pH gradient isoelectric focusing in the first dimension: an interlaboratory comparison. Electrophoresis 15:1205–1211.
  • Dell, G., and Gaston K.. 2001. Human papillomaviruses and their role in cervical cancer. Cell. Mol. Life Sci. 58:1923–1942.
  • Dever, T. E. 2002. Gene-specific regulation by general translation factors. Cell 108:545–556.
  • Donze, O., Dostie J., and Sonenberg N.. 1999. Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression. Virology 256:322–329.
  • Dreyling, M. H., Roulston D., Bohlander S. K., Vardiman J., and Olopade O. I.. 1998. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer 22:72–78.
  • Dunn, M. J., and Corbett J. M.. 1996. Two-dimensional polyacrylamide gel electrophoresis. Methods Enzymol. 271:177–203.
  • Espert, L., Degols G., Gongora C., Blondel D., Williams B. R., Silverman R. H., and Mechti N.. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 278:16151–16158.
  • Gale, M., Jr., Tan S. L., and Katze M. G.. 2000. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64:239–280.
  • Ghosh, S., May M. J., and Kopp E. B.. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225–260.
  • Gu, Z., Pim D., Labrecque S., Banks L., and Matlashewski G.. 1994. DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6. Oncogene 9:629–633.
  • Guccione, E., Massimi P., Bernat A., and Banks L.. 2002. Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins. Virology 293:20–25.
  • Harding, H. P., Calfon M., Urano F., Novoa I., and Ron D.. 2002. Transcriptional and translational control in the Mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 18:575–599.
  • Harding, H. P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., and Ron D.. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6:1099–1108.
  • He, B., Chou J., Liebermann D. A., Hoffman B., and Roizman B.. 1996. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the γ134.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70:84–90.
  • Hershey, J. W. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60:717–755.
  • Hirt, R. P., Muller S., Embley T. M., and Coombs G. H.. 2002. The diversity and evolution of thioredoxin reductase: new perspectives. Trends Parasitol. 18:302–308.
  • Ishikawa, H., Heaney A. P., Yu R., Horwitz G. A., and Melmed S.. 2001. Human pituitary tumor-transforming gene induces angiogenesis. J. Clin. Endocrinol. Metab. 86:867–874.
  • Ishikawa, S., Kai M., Tamari M., Takei Y., Takeuchi K., Bandou H., Yamane Y., Ogawa M., and Nakamura Y.. 1997. Sequence analysis of a 685-kb genomic region on chromosome 3p22-p21.3 that is homozygously deleted in a lung carcinoma cell line. DNA Res. 4:35–43.
  • Jagus, R., Joshi B., and Barber G. N.. 1999. PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol. 31:123–138.
  • Kastner, P., and Chan S.. 2001. Function of RARα during the maturation of neutrophils. Oncogene 20:7178–7185.
  • Katze, M. G. 1995. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3:75–78.
  • Katze, M. G., He Y., and Gale M., Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675–687.
  • Kaufman, R. J. 2000. Double-stranded RNA-activated protein kinase PKR, p. 503–527. In Sonenberg N., Hershey J. W. B., and Mathews M. B. (ed.), Translational control of gene expression. Cold Spring Harbor Laboratory Press, New York, N.Y.
  • Kehmeier, E., Ruhl H., Voland B., Stoppler M. C., Androphy E., and Stoppler H.. 2002. Cellular steady-state levels of “high risk” but not “low risk” human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 299:72–87.
  • Kimball, S. R. 2001. Regulation of translation initiation by amino acids in eukaryotic cells. Prog. Mol. Subcell. Biol. 26:155–184.
  • Kirchhoff, S., Koromilas A. E., Schaper F., Grashoff M., Sonenberg N., and Hauser H.. 1995. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11:439–445.
  • Kirfel, J., Magin T. M., and Reichelt J.. 2003. Keratins: a structural scaffold with emerging functions. Cell. Mol. Life Sci. 60:56–71.
  • Koromilas, A. E., Li S., and Matlashewski G.. 2001. Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev. 12:157–170.
  • Kumar, A., Yang Y. L., Flati V., Der S., Kadereit S., Deb A., Haque J., Reis L., Weissmann C., and Williams B. R.. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J. 16:406–416.
  • Leib, D. A. 2002. Counteraction of interferon-induced antiviral responses by herpes simplex viruses. Curr. Top. Microbiol. Immunol. 269:171–185.
  • Leone, P. E., Mendiola M., Alonso J., Mino C., and Pestana A.. 2003. Implications of a RAD54L polymorphism (2290C/T) in human meningiomas as a risk factor and/or a genetic marker. BMC Cancer 3:6.
  • Li, S., and Koromilas A. E.. 2001. Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. J. Biol. Chem. 276:13881–13890.
  • Li, S., Labrecque S., Gauzzi M. C., Cuddihy A. R., Wong A. H., Pellegrini S., Matlashewski G. J., and Koromilas A. E.. 1999. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18:5727–5737.
  • Li, S., Nagai K., and Koromilas A. E.. 2000. A diminished activation capacity of the interferon-inducible protein kinase PKR in human T lymphocytes. Eur. J. Biochem. 267:1598–1606.
  • Mantovani, F., and Banks L.. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874–7887.
  • Munger, K. 2002. The role of human papillomaviruses in human cancers. Front. Biosci. 7:d641–d649.
  • Munger, K., and Howley P. M.. 2002. Human papillomavirus immortalization and transformation functions. Virus Res. 89:213–228.
  • Nanbo, A., and Takada K.. 2002. The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis. Rev. Med. Virol. 12:321–326.
  • Neubig, R. R., and Siderovski D. P.. 2002. Regulators of G-protein signalling as new central nervous system drug targets. Nat. Rev. Drug Discov. 1:187–197.
  • Novak, J. P., Sladek R., and Hudson T. J.. 2002. Characterization of variability in large-scale gene expression data: implications for study design. Genomics 79:104–113.
  • Novoa, I., Zeng H., Harding H. P., and Ron D.. 2001. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α. J. Cell Biol. 153:1011–1022.
  • Novoa, I., Zhang Y., Zeng H., Jungreis R., Harding H. P., and Ron D.. 2003. Stress-induced gene expression requires programmed recovery from translational repression. EMBO J. 22:1180–1187.
  • Olofsson, B. 1999. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell. Signal. 11:545–554.
  • Pataer, A., Vorburger S. A., Barber G. N., Chada S., Mhashilkar A. M., Zou-Yang H., Stewart A. L., Balachandran S., Roth J. A., Hunt K. K., and Swisher S. G.. 2002. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res. 62:2239–2243.
  • Payton, M., and Coats S.. 2002. Cyclin E2, the cycle continues. Int. J. Biochem. Cell Biol. 34:315–320.
  • Perelman, B., Dafni N., Naiman T., Eli D., Yaakov M., Feng T. L., Sinha S., Weber G., Khodaei S., Sancar A., Dotan I., and Canaani D.. 1997. Molecular cloning of a novel human gene encoding a 63-kDa protein and its sublocalization within the 11q13 locus. Genomics 41:397–405.
  • Protopopov, A., Kashuba V., Zabarovska V. I., Muravenko O. V., Lerman M. I., Klein G., and Zabarovsky E. R.. 2003. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res. 63:404–412.
  • Puthalakath, H., and Strasser A.. 2002. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9:505–512.
  • Rajan, P., Swaminathan S., Zhu J., Cole C. N., Barber G., Tevethia M. J., and Thimmapaya B.. 1995. A novel translational regulation function for the simian virus 40 large-T antigen gene. J. Virol. 69:785–795.
  • Ramos-Morales, F., A. Dominguez, F. Romero, R. Luna, M. C. Multon, J. A. Pintor-Toro, and M. Tortolero. 2000. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene 19:403–409.
  • Ron, D. 2002. Translational control in the endoplasmic reticulum stress response. J. Clin. Investig. 110:1383–1388.
  • Roulston, A., Marcellus R. C., and Branton P. E.. 1999. Viruses and apoptosis. Annu. Rev. Microbiol. 53:577–628.
  • Sambrook, J., Fritsch E. F., and Maniatis T.. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York, N.Y.
  • Sanchez, J. C., Rouge V., Pisteur M., Ravier F., Tonella L., Moosmayer M., Wilkins M. R., and Hochstrasser D. F.. 1997. Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis 18:324–327.
  • Sauane, M., Gopalkrishnan R. V., Sarkar D., Su Z. Z., Lebedeva I. V., Dent P., Pestka S., and Fisher P. B.. 2003. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14:35–51.
  • Scheuner, D., Song B., McEwen E., Liu C., Laybutt R., Gillespie P., Saunders T., Bonner-Weir S., and Kaufman R. J.. 2001. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol. Cell 7:1165–1176.
  • Schramm, L., and Hernandez N.. 2002. Recruitment of RNA polymerase III to its target promoters. Genes Dev. 16:2593–2620.
  • Shaulian, E., and Karin M.. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131–E136.
  • Sheikh, M. S., Hollander M. C., and Fornance A. J., Jr. 2000. Role of Gadd45 in apoptosis. Biochem. Pharmacol. 59:43–45.
  • Stark, G. R., Kerr I. M., Williams B. R., Silverman R. H., and Schreiber R. D.. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227–264.
  • Swaminathan, S., Rajan P., Savinova O., Jagus R., and Thimmapaya B.. 1996. Simian virus 40 large-T bypasses the translational block imposed by the phosphorylation of eIF-2 alpha. Virology 219:321–323.
  • Tan, S. L., and Katze M. G.. 1999. The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? J. Interferon Cytokine Res. 19:543–554.
  • Tan, S. L., Tareen S. U., Melville M. W., Blakely C. M., and Katze M. G.. 2002. The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation. J. Biol. Chem. 277:36109–36117.
  • Taniguchi, T., Ogasawara K., Takaoka A., and Tanaka N.. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623–655.
  • Ung, T. L., Cao C., Lu J., Ozato K., and Dever T. E.. 2001. Heterologous dimerization domains functionally substitute for the double-stranded RNA binding domains of the kinase PKR. EMBO J. 20:3728–3737.
  • Wallach, D., Varfolomeev E. E., Malinin N. L., Goltsev Y. V., Kovalenko A. V., and Boldin M. P.. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331–367.
  • Warden, S. M., Richardson C., O'Donnell J., Jr., Stapleton D., Kemp B. E., and Witters L. A.. 2001. Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem. J. 354:275–283.
  • Wong, A. H., Durbin J. E., Li S., Dever T. E., Decker T., and Koromilas A. E.. 2001. Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. J. Biol. Chem. 276:13727–13737.
  • Wood, Z. A., Schroder E., Robin H. J., and Poole L. B.. 2003. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28:32–40.
  • Yao, X., Abrieu A., Zheng Y., Sullivan K. F., and Cleveland D. W.. 2000. CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint. Nat. Cell Biol. 2:484–491.
  • Yodoi, J., Nakamura H., and Masutani H.. 2002. Redox regulation of stress signals: possible roles of dendritic stellate TRX producer cells (DST cell types). Biol. Chem. 383:585–590.
  • Zapata, J. M., and Reed J. C.. 2002. TRAF1: lord without a RING. Sci. STKE 2002:PE27.
  • Zhu, S., Sobolev A. Y., and Wek R. C.. 1996. Histidyl-tRNA synthetase-related sequences in GCN2 protein kinase regulate in vitro phosphorylation of eIF-2. J. Biol. Chem. 271:24989–24994.
  • zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342–350.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.